☆ 3.8 Letter

Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax

HEMATOLOGY TRANSFUSION AND CELL THERAPY (2022)

Get Full Text
Add to Collection

Journal

HEMATOLOGY TRANSFUSION AND CELL THERAPY
Volume 44, Issue 1, Pages 124-127

Publisher

ELSEVIER
DOI: 10.1016/j.htct.2021.01.004

Keywords

-

Categories

Oncology Hematology

Funding

  1. SAo Paulo Research Foun-dation (FAPESP) [2019/23864-7, 2018/19372-9, 2019/01700-2]
  2. Conselho Nacional de Desenvolvimento Cientifico e Tec-nologico (CNPq) [402587/2016-2]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.